Two different regenerative injections in patients diagnosed with secondary hip osteoarthritis: A report of two cases


Creative Commons License

Say F., Büyükceran İ., Coşkun S.

Journal of Experimental and Clinical Medicine (Turkey), cilt.38, sa.2, ss.204-207, 2021 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.52142/omujecm.38.2.27
  • Dergi Adı: Journal of Experimental and Clinical Medicine (Turkey)
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, EMBASE
  • Sayfa Sayıları: ss.204-207
  • Anahtar Kelimeler: Autologous conditioned serum, Developmental dysplasia of the hip, Platelet rich plasma
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Non-surgical treatment options are limited in hip osteoarthritis secondary to developmental dysplasia of the hip (DDH). Treatment of Autologous Conditioned Serum (ACS) is based on the high level of anti-inflammatory cytokine production of leukocytes in peripheral blood. It is an effective treatment option which contains the cytokines and the growth factors. Platelet Rich Plasma (PRP) is a form of treatment that stimulates natural healing steps through growth factors in platelets. In this case report we aimed to present the results of ACS and PRP injection in two patients who developed secondary coxarthrosis after DDH surgery. At the 1-year follow-up examination, patient’s functional scores improved and requirement for non-steroid anti-inflammatory drugs had significantly reduced. Regenerative injections either autologous conditioned serum or platelet rich plasma treatments are safe and effective treatments and can be recommended particularly for cases of secondary hip osteoarthritis associated with DDH.